Why Mira Pharmaceuticals Stock Is Moving Higher Monday
Why Mira Pharmaceuticals Stock Is Moving Higher Monday
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares are trading higher after the company said testing has confirmed its preliminary beliefs regarding a new potential treatment for neurological and neuropsychiatric disorders.
MIRA药品公司（纳斯达克股票代码：MIRA）称，测试证实其初步结论，即该公司拥有一种新的潜在神经和神经精神障碍治疗方法。股价上涨。
The Details: The company is currently evaluating a pharmaceutical drug, MIRA-55, as a possible treatment for anxiety and cognitive decline.
具体：该公司正在评估一种药品MIRA-55作为焦虑和认知衰退的可能治疗方法。
Preclinical tests showed promising results including stronger efficacy when compared to THC. Different dosage levels of THC may weaken its effectiveness, however, MIRA-55 maintained its efficacy across dosage levels.
临床前试验显示了令人鼓舞的结果，包括与THC相比更强的功效。不同剂量的THC可能会削弱其有效性，但MIRA-55在剂量水平上维持其功效。
In addition, the novel drug outperformed THC in reducing anxiety driven behaviors and demonstrated a promising safety profile, potentially safer for human therapeutic use.
此外，这种新型药物在降低焦虑驱动行为方面的表现优于THC，并展现了有前途的安全鉴定档案，可能更安全用于人类治疗。
"Our dedication to developing innovative treatments continues to drive our research and development efforts. We will be conducting additional preclinical studies to advance us closer to an Investigational New Drug (IND) application for MIRA-55," said Erez Aminov, CEO and chairman of Mira Pharmaceuticals.
Mira药品公司的首席执行官兼董事长Erez Aminov表示：“我们致力于开发创新治疗方法，这将推动我们的研究和开发工作。我们将进行额外的临床前研究，使我们更接近MIRA-55的新药临床申请。”
Related Link: Analyst Expectations For Sage Therapeutics's Future
相关链接: 分析师对Sage Therapeutics未来的预期
MIRA Price Action: MIRA Pharmaceuticals stock is trading 30.5% higher at 76 cents at the time of publication per data from Benzinga Pro.
Mira药品股价正在上涨，根据Benzinga Pro的数据，股价在发表时以76美分的价格上涨30.5%。
Image: 1569173 from Pixabay.
图片来源：Pixabay。